Qingdao Haier Biomedical Co.,Ltd

Equities

688139

CNE100003P25

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
36.93 ^CNY	+7.17%		+13.18%	-8.86%

Apr. 25	Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024.	CI

Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.

January 03, 2023

From July 1, 2022 to December 31, 2022, the company has repurchased 676,994 shares, representing 0.21% for CNY 43.31 million. With this, the company has completed the repurchase of 1,436,614 shares, representing 0.45% for CNY 98.02 million under the buyback announced on February 7, 2022.

Latest news about Qingdao Haier Biomedical Co.,Ltd

Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Tranche Update on Qingdao Haier Biomedical Co.,Ltd's Equity Buyback Plan announced on February 9, 2024.	Apr. 01	CI
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
Qingdao Haier Biomedical Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	Feb. 08	CI
Qingdao Haier Biomedical Co.,Ltd authorizes a Buyback Plan.	Feb. 07	CI
CICC Elects Chairman, Vice Chairman	Nov. 13	MT
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 80 Yuan From 100 Yuan, Keeps at Buy	23-10-27	MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Jefferies Adjusts Qingdao Haier Biomedical's Price Target to 100 Yuan From 120 Yuan, Keeps at Buy	23-08-30	MT
Qingdao Haier Biomedical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Shanghai Chaoli'an Technology Co., Ltd. announced that it expects to receive CNY 43 million in funding from Qingdao Haier Biomedical Co.,Ltd	23-06-06	CI
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Jefferies Adjusts Qingdao Haier Biomedical’s Price Target to 120 Yuan From 126 Yuan, Keeps at Buy	23-03-30	MT
Qingdao Haier Biomedical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.	23-02-03	CI
Qingdao Haier Biomedical Co., Ltd's Equity Buyback announced on February 7, 2022, has expired with 1,459,586 shares, representing 0.46% for CNY 99.69 million.	23-02-01	CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.	23-01-03	CI
Beijing residents break free from COVID lockdown	22-11-26	RE
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-10	CI
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Suzhou Basecare Signs Strategic Collaboration Framework Deal with Qingdao Haier Biomedical	22-07-13	MT
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.	22-06-30	CI
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.	22-04-01	CI
Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-16	CI

Chart Qingdao Haier Biomedical Co.,Ltd

Duration

Period

More charts

Company Profile

Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-22 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Qingdao Haier Biomedical Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

36.93 CNY

Average target price

57.5 CNY

Spread / Average Target

+55.70%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
QINGDAO HAIER BIOMEDICAL CO.,LTD	-8.86%	1.5B
THERMO FISHER SCIENTIFIC	+7.92%	218B
DANAHER CORPORATION	+6.99%	182B
INTUITIVE SURGICAL, INC.	+11.71%	132B
BOSTON SCIENTIFIC CORPORATION	+26.92%	108B
EDWARDS LIFESCIENCES CORPORATION	+12.83%	52.98B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	47.59B
AGILENT TECHNOLOGIES, INC.	-0.67%	39.96B
GE HEALTHCARE TECHNOLOGIES INC.	+12.09%	39.22B
RESMED, INC.	+26.46%	26.94B

Other Advanced Medical Equipment & Technology